{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T15:51:54Z","timestamp":1781452314833,"version":"3.54.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current myocardial infarction treatments focus on improving hemodynamics rather than addressing the problem of lost myocardium impairing left ventricular function. Epicardial infarct repair with a bioactive patch placed on the ischemic area is an emerging approach to promote endogenous myocardial repair. We report the use of a second-generation CorMatrix-extracellular matrix (ECM) patch as an adjunct to surgical revascularization in treating a young patient with diffuse, multivessel coronary artery disease unamenable to PCI and a large anterior myocardial infarction. The progressive myocardial scar shrinkage and increase in left ventricular ejection fraction from 10 to 51% are generally not observed with surgical revascularization therapy alone, suggesting this new patch has adjunctive potential to current revascularization therapy.<\/jats:p>","DOI":"10.1186\/s13019-023-02358-3","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T16:03:22Z","timestamp":1693584202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Second-generation extracellular matrix patch for epicardial infarct repair"],"prefix":"10.1186","volume":"18","author":[{"given":"Arjun","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin B.","family":"Marcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Matheny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blase A.","family":"Carabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanhua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Douglas","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"issue":"8","key":"2358_CR1","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2217\/fca-2021-0017","volume":"17","author":"V Vasanthan","year":"2021","unstructured":"Vasanthan V, Biglioli M, Hassanabad AF, Dundas J, Matheny RG, Fedak PW. The CorMatrix Cor\u2122 PATCH for epicardial infarct repair. Future Cardiol. 2021;17(8):1297\u2013305.","journal-title":"Future Cardiol"},{"issue":"6","key":"2358_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1378\/chest.73.6.843","volume":"73","author":"MC Fishbein","year":"1978","unstructured":"Fishbein MC, Maclean D, Maroko PR. The histopathologic evolution of myocardial infarction. Chest. 1978;73(6):843\u20139.","journal-title":"Chest"},{"issue":"1","key":"2358_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12265-010-9244-0","volume":"4","author":"RC Gorman","year":"2011","unstructured":"Gorman RC, Jackson BM, Gorman JH, et al. Infarct restraint to limit adverse ventricular remodeling. J Cardiovasc Transl Res. 2011;4(1):73\u201381.","journal-title":"J Cardiovasc Transl Res"},{"issue":"5","key":"2358_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.healun.2016.01.012","volume":"35","author":"HE Mewhort","year":"2016","unstructured":"Mewhort HE, Turnbull JD, Satriano A, et al. Epicardial infarct repair with bioinductive extracellular matrix promotes vasculogenesis and myocardial recovery. J Heart Lung Transplant. 2016;35(5):661\u201370.","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"2358_CR5","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.jtcvs.2013.08.005","volume":"147","author":"HE Mewhort","year":"2014","unstructured":"Mewhort HE, Turnbull JD, Meijndert HC, Ngu JM, Fedak PW. Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling. J Thorac Cardiovasc Surg. 2014;147(5):1650\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"2358_CR6","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.jtcvs.2013.10.055","volume":"148","author":"MW Gerdisch","year":"2014","unstructured":"Gerdisch MW, Shea RJ, Barron MD. Clinical experience with CorMatrix extracellular matrix in the surgical treatment of mitral valve disease. J Thorac Cardiovasc Surg. 2014;148(4):1370\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"2358_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/imi.0000000000000014","volume":"8","author":"B Yanagawa","year":"2013","unstructured":"Yanagawa B, Rao V, Yau TM, Cusimano RJ. Initial experience with intraventricular repair using CorMatrix extracellular matrix. Innovations (Phila). 2013;8(5):348\u201352.","journal-title":"Innovations (Phila)"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02358-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02358-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02358-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T15:30:42Z","timestamp":1700321442000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-023-02358-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1186\/s13019-023-02358-3","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"13 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Robert G. Matheny is the Chief Scientific and Medical Officer of CorMatrix Cardiovascular Inc. All other authors reported no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Consent from the institutional review board was waived, being clinical case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"255"}}